Business Wire

VOICEMOD

15.6.2022 14:07:40 CEST | Business Wire | Press release

Share
Voicemod Launches World’s First Real-Time AI-Powered Voice Conversion for Everyone

Voicemod (www.voicemod.net ), the world leader in augmented voice and interactive audio, ​​is releasing its proprietary, first-of-its-kind voice conversion product powered by artificial intelligence (AI). This new collection of AI voices is a giant leap in innovation in developing speech-to-speech voice transformation capabilities. Voicemod empowers people to find their sonic and gender identity in digital spaces and create their personalized voice avatars — in real time.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220615005160/en/

KEY POINTS

  • AI voices unlock a previously impossible level of customization in online audio expression, furthering Voicemod’s mission to allow users to sound how they want to sound.
  • The real-time speech-to-speech voice conversion engine makes it possible to create realistic synthetic voices while keeping facets of a user’s original voice such as emotion, accentuation, and pacing, creating unique sonic identities.
  • This technology will enable Voicemod’s millions of users, ranging from gamers and roleplayers to people not comfortable with their voice, to better express themselves online.

Voicemod’s technology innovation in speech-to-speech voice conversion allows for personal customization or integration of the user’s personality. It offers people extensive freedom in how much of their natural voice they keep or mix, resulting in a unique, personalized voice avatar that fits their needs on a case-by-case basis for work or play.

Speech-to-speech AI-based voice technology not only expands the degree to which users can alter a source voice, but it also provides the ability to add or remove accents. Gamers and roleplayers can speak with an accurate re-creation of their favorite character, without the need for voice acting.

"This is a first step into the future. With further development of AI voices, it's not only going to help people like me in the trans community, it's going to change the meta of the world," said Kairi Caitlyn , a VTuber on Twitch and the world's top Spellbreak competitive player/coach, as well as an esports gaming community organizer.

The Voicemod AI voices, available now in beta mode, range from realistic-sounding human voices to ones with added effects to complete fantasy characters. For example, in addition to Voicemod’s masculine and feminine-sounding “Bob” and “Alice” voices, the celebrity-inspired “Morgan” voice offers fantasy characters such as Celestial, Narrator, The President, and The General. The technology launch contains multiple additional voices, combining both AI and classic sound design techniques to enable users to instantly turn into a pilot, an astronaut, and even digital entities, opening more creative possibilities than ever before.

“Voicemod AI Voices are lots of fun and give a richer experience for participants or for scenarios you're running your players through. Playing sci-fi? Grab that astronaut's voice! Want to sound like a deity? Morgan is your best bet. I can't wait to start using this for my sessions,” said Cypheroftyr , an American streamer and TTRPG DEI consultant and developer known as the founder and director of the non-profit organization I Need Diverse Games .

With real-time voice-to-voice conversion technology, Voicemod is creating an entirely new toolset with which people can explore their audio self-expression for more genuine person-to-person communication.

“We’re very excited to introduce the next stage in audio expression technology to our passionate community of Voicemod users — and to the rest of the world,” said Voicemod CEO and co-founder Jaime Bosch. “Integrating the power of real-time AI voices into our engine, combined with our growing catalog of IP partnerships, enables a previously impossible level of customization in audio expression online and in the metaverse.”

Voicemod is shaping the future of communication by building industry-leading social audio tools that make it easy for anyone to create, customize, enhance, and control the way they sound online, in social apps, and even in the metaverse. The company’s current suite of technology products already provides incredible capabilities to enthusiastic Voicemod users, with tools such as the recently launched PowerPitch technology for building realistic, persistent online voice identities for gaming, work, school, role-playing, or social communication.

Today, all Voicemod users can start experimenting with AI voices on their PCs, requesting their priority access at http://voicemod.net/ai-beta/ . Become a Voicemod user to find your true voice persona for more immersive, enjoyable, and entertaining gaming and communications online.

Resources

  • Watch a short video for more details on AI voices.
  • See the Voicemod newsroom for details on recent licensing agreements for popular intellectual property (IP) including games, emoticons, music, and TV titles.
  • Consult the Voicemod Developer Kit —compatible for both PC and Mac— for platforms that support Voicemod technology, as well as how B2B developers, creators, and OEMs can integrate Voicemod's real-time voice conversion technology directly into their games, applications, social apps, and hardware to drive new levels of user engagement and retention.

About Voicemod

Voicemod is the leader in real-time audio augmentation. Developers trust Voicemod’s audio technology to help end-users create virtual voices and define their sonic identities. As companies strive to build a responsible metaverse, Voicemod is the tool that helps gamers, content creators, and professionals of all skill levels find the voice that best expresses themselves as they play, work, create, and entertain. Discover more at www.voicemod.net .

Link:

ClickThru

Social Media:

https://www.facebook.com/voicemod

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release

Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye